ZA200102636B - Method of treating a parasitic infection. - Google Patents

Method of treating a parasitic infection.

Info

Publication number
ZA200102636B
ZA200102636B ZA200102636A ZA200102636A ZA200102636B ZA 200102636 B ZA200102636 B ZA 200102636B ZA 200102636 A ZA200102636 A ZA 200102636A ZA 200102636 A ZA200102636 A ZA 200102636A ZA 200102636 B ZA200102636 B ZA 200102636B
Authority
ZA
South Africa
Prior art keywords
treating
parasitic infection
parasitic
infection
Prior art date
Application number
ZA200102636A
Other languages
English (en)
Inventor
Hafid Abdelaali Benchaoui
Antoinette Beaton Dra Jernigan
Mark Payne-Johnson
Timothy George Rowan
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA200102636B publication Critical patent/ZA200102636B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200102636A 2000-04-03 2001-03-30 Method of treating a parasitic infection. ZA200102636B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0008353.5A GB0008353D0 (en) 2000-04-03 2000-04-03 Method of treating a parasitic infection

Publications (1)

Publication Number Publication Date
ZA200102636B true ZA200102636B (en) 2003-02-28

Family

ID=9889246

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200102636A ZA200102636B (en) 2000-04-03 2001-03-30 Method of treating a parasitic infection.

Country Status (10)

Country Link
EP (1) EP1142577A3 (xx)
JP (1) JP2001316269A (xx)
KR (1) KR20010095240A (xx)
AU (1) AU3334701A (xx)
CA (1) CA2343452A1 (xx)
GB (1) GB0008353D0 (xx)
HU (1) HUP0101347A3 (xx)
IL (1) IL142256A0 (xx)
NZ (1) NZ510885A (xx)
ZA (1) ZA200102636B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
WO2012054331A1 (en) 2010-10-20 2012-04-26 Galderma S.A. Method of treating otitis externa using macrocyclic lactone compound
CA2811924C (en) 2010-10-20 2015-06-16 Galderma S.A. Method of treating hemorrhoids using macrocyclic lactone compound
CN103360444B (zh) * 2012-04-03 2016-05-11 浙江海正药业股份有限公司 抗寄生虫药赛拉菌素的合成新工艺
PL3595441T3 (pl) * 2017-03-17 2023-12-04 Krka, D.D., Novo Mesto Stabilna kompozycja weterynaryjna do stosowania miejscowego

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831017A (en) * 1987-06-29 1989-05-16 Merck & Co., Inc. Increased litter size in monogastric domestic animals after treatment in mid-gestation of gravid female with avermectin or milbemycin compound
US5015630A (en) * 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
GB9300883D0 (en) * 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents

Also Published As

Publication number Publication date
KR20010095240A (ko) 2001-11-03
HU0101347D0 (en) 2001-06-28
GB0008353D0 (en) 2000-05-24
NZ510885A (en) 2002-11-26
IL142256A0 (en) 2002-03-10
AU3334701A (en) 2001-10-04
JP2001316269A (ja) 2001-11-13
EP1142577A2 (en) 2001-10-10
CA2343452A1 (en) 2001-10-03
HUP0101347A2 (hu) 2001-11-28
EP1142577A3 (en) 2002-01-23
HUP0101347A3 (en) 2003-10-28

Similar Documents

Publication Publication Date Title
AU2002215125A1 (en) Well treatment method
GB0014969D0 (en) Novel method of treatment
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
GB0028264D0 (en) Well treatment
ZA200108446B (en) Novel method of treatment.
GB0129976D0 (en) Treatment method
AUPQ533700A0 (en) Soil treatment method
GB2370694B (en) Implantation method
AU2001286983A1 (en) Method of treatment
MXPA01008512A (es) Metodo para el tratamiento de lana.
EP1294411A4 (en) NEW TREATMENT AGAINST COUGH
GB0006958D0 (en) Method of manufacturing a transistor
GB0120147D0 (en) Treatment method
MXPA03003347A (es) Procedimiento para purificacion de pravastatina.
ZA200102636B (en) Method of treating a parasitic infection.
DE60140597D1 (de) Vakuumbehandlungsverfahren
GB2369198B (en) Ashing method
EP1267911A4 (en) TREATMENT METHOD
AU2001262177A1 (en) Method of treatment
HK1039872A2 (en) A wastewater treatment method
AU2002212876A1 (en) Method for integrated water treatment
EP1335734A4 (en) METHOD FOR TREATING HIV
GB0016693D0 (en) Cough treatment
GB0126253D0 (en) Treatment method
AU3713201A (en) A method of treatment